123 related articles for article (PubMed ID: 32840699)
1. Increasing accrual of minority patients in breast cancer clinical trials.
Trant AA; Walz L; Allen W; DeJesus J; Hatzis C; Silber A
Breast Cancer Res Treat; 2020 Nov; 184(2):499-505. PubMed ID: 32840699
[TBL] [Abstract][Full Text] [Related]
2. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
[TBL] [Abstract][Full Text] [Related]
3. Barriers to minority participation in breast carcinoma prevention trials.
Grann VR; Jacobson JS; Troxel AB; Hershman D; Karp J; Myers C; Neugut AI
Cancer; 2005 Jul; 104(2):374-9. PubMed ID: 15937913
[TBL] [Abstract][Full Text] [Related]
4. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
[TBL] [Abstract][Full Text] [Related]
5. Insufficient Reporting of Race and Ethnicity in Breast Cancer Clinical Trials.
Keegan G; Crown A; DiMaggio C; Joseph KA
Ann Surg Oncol; 2023 Nov; 30(12):7008-7014. PubMed ID: 37658271
[TBL] [Abstract][Full Text] [Related]
6. Minority Enrollment to Clinical Trials: Road to Increased Access.
Vose J
Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
8. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
[TBL] [Abstract][Full Text] [Related]
9. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
[TBL] [Abstract][Full Text] [Related]
10. An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials.
Markman M; Petersen J; Montgomery R
J Cancer Res Clin Oncol; 2008 Jan; 134(1):115-8. PubMed ID: 17598129
[TBL] [Abstract][Full Text] [Related]
11. Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.
Riner AN; Girma S; Vudatha V; Mukhopadhyay N; Skoro N; Gal TS; Freudenberger DC; Herremans KM; George TJ; Trevino JG
J Clin Oncol; 2022 Jul; 40(20):2193-2202. PubMed ID: 35316089
[TBL] [Abstract][Full Text] [Related]
12. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
[TBL] [Abstract][Full Text] [Related]
13. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
[TBL] [Abstract][Full Text] [Related]
14. Perceived Institutional Barriers Among Clinical and Research Professionals: Minority Participation in Oncology Clinical Trials.
Niranjan SJ; Wenzel JA; Martin MY; Fouad MN; Vickers SM; Konety BR; Durant RW
JCO Oncol Pract; 2021 May; 17(5):e666-e675. PubMed ID: 33974821
[TBL] [Abstract][Full Text] [Related]
15. Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials.
Saini G; Gogineni K; Kittles RA; Aneja R
Breast Cancer Res Treat; 2021 Jun; 187(3):605-611. PubMed ID: 34080093
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in European Breast Cancer Clinical Trials.
Bania A; Adamou A; Saloustros E
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730678
[TBL] [Abstract][Full Text] [Related]
17. Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials.
Napoles A; Cook E; Ginossar T; Knight KD; Ford ME
Adv Cancer Res; 2017; 133():77-94. PubMed ID: 28052822
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.
Simon MS; Du W; Flaherty L; Philip PA; Lorusso P; Miree C; Smith D; Brown DR
J Clin Oncol; 2004 Jun; 22(11):2046-52. PubMed ID: 15082724
[TBL] [Abstract][Full Text] [Related]
19. Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis.
Ledesma Vicioso N; Lin D; Gomez DR; Yang JT; Lee NY; Rimner A; Yamada Y; Zelefsky MJ; Kalman NS; Rutter CE; Kotecha RR; Mehta MP; Panoff JE; Chuong MD; Salner AL; Ostroff JS; Diamond LC; Mathis NJ; Cahlon O; Pfister DG; Zhang Z; Chino F; Tsai J; Gillespie EF
JCO Oncol Pract; 2022 May; 18(5):e780-e785. PubMed ID: 35544650
[TBL] [Abstract][Full Text] [Related]
20. Involving South Asian patients in clinical trials.
Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
